These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21614172)
1. Analysis of mTOR inhibition-involved pathway in ovarian clear cell adenocarcinoma. Harasawa M; Yasuda M; Hirasawa T; Miyazawa M; Shida M; Muramatsu T; Douguchi K; Matsui N; Takekoshi S; Kajiwara H; Yoshiyuki Osamura R; Mikami M Acta Histochem Cytochem; 2011 Apr; 44(2):113-8. PubMed ID: 21614172 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma. Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088 [TBL] [Abstract][Full Text] [Related]
4. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial. Hirasawa T; Miyazawa M; Yasuda M; Shida M; Ikeda M; Kajiwara H; Matsui N; Fujita M; Muramatsu T; Mikami M Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586 [TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795 [TBL] [Abstract][Full Text] [Related]
6. Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma. Tamura K; Yoshie M; Miyajima E; Kano M; Tachikawa E ISRN Pharmacol; 2013; 2013():279593. PubMed ID: 23819061 [TBL] [Abstract][Full Text] [Related]
7. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960 [TBL] [Abstract][Full Text] [Related]
8. Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies. Ataie-Kachoie P; Pourgholami MH; Bahrami-B F; Badar S; Morris DL Am J Cancer Res; 2015; 5(2):575-88. PubMed ID: 25973298 [TBL] [Abstract][Full Text] [Related]
9. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling. Liu NN; Zhao N; Cai N IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388 [TBL] [Abstract][Full Text] [Related]
10. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy. Wei J; Jiang H; Gao H; Wang G Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905 [TBL] [Abstract][Full Text] [Related]
11. Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. Miyazawa M; Yasuda M; Fujita M; Hirabayashi K; Hirasawa T; Kajiwara H; Muramatsu T; Miyazaki S; Harasawa M; Matsui N; Ogane N; Murakami M; Mikami M; Yanase T; Osamura RY J Obstet Gynaecol Res; 2010 Apr; 36(2):448-53. PubMed ID: 20492406 [TBL] [Abstract][Full Text] [Related]
12. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
13. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways. Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002 [TBL] [Abstract][Full Text] [Related]
14. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma. Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943 [TBL] [Abstract][Full Text] [Related]
17. mTOR activates hypoxia-inducible factor-1α and inhibits neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia. Chen H; Xiong T; Qu Y; Zhao F; Ferriero D; Mu D Neurosci Lett; 2012 Jan; 507(2):118-23. PubMed ID: 22178140 [TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway. Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]